CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR Surgical has secured US Food and Drug Administration (FDA) clearance ...
Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform, Versius ...
Medical Device Network on MSN
CMR Surgical’s Versius robot secures CE mark for paediatric treatment
CMR becomes the third surgical robotics company alongside Intuitive Surgical and SHURUI Robotics to obtain a CE mark in Europe for paediatric treatment.
CMR Surgical receives CE Mark for use of Versius in paediatric surgery Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January 2026, ...
Cambridge, United Kingdom. 20 September 2023 0700 (BST). CMR Surgical (CMR or ‘the Company’) – the global surgical robotics business – has today announced that its next-generation Versius ® Surgical ...
Regulatory clearance of CMR’s most advanced system paves the way for upcoming US commercial launch Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results